Xcopri Patient Tips: 7 things you should know Easy-to-read patient tips for Xcopri covering how it works, benefits, risks, and best practices.

#Xcopri treats partial-onset seizures in adults. Side effects include dizziness, drowsiness, double vision, and clumsiness. It's a Schedule V controlled substance requiring careful titration when starting and gradual discontinuation over two weeks to prevent withdrawal.

SK Life Science Unveils Powerful New Campaign for XCOPRI, Redefining Epilepsy Treatment in America This innovative campaign by SK Life Science aims to change perceptions of epilepsy treatment. It emphasizes patient empowerment, addressing fears and promoting informed discussions between patients and their doctors.

SK Life Science Unveils Powerful New Campaign for XCOPRI, Redefining Epilepsy Treatment in America #USA #SK_Life_Science #Paramus #Epilepsy #XCOPRI

SK Life Science to Present Groundbreaking XCOPRI Data at AAN 2025 Annual Meeting At the 2025 AAN Annual Meeting, SK Life Science will present pivotal research on XCOPRI, highlighting its efficacy in epilepsy management, with real-world insights.

SK Life Science to Present Groundbreaking XCOPRI Data at AAN 2025 Annual Meeting #United_States #San_Diego #Cenobamate #SK_Life_Science #XCOPRI

New Epilepsia Supplement Reveals Advances in Antiseizure Medications for Epilepsy Patients The latest Epilepsia supplement showcases the potential of third-generation antiseizure medications in achieving seizure freedom for patients with epilepsy, particularly those resistant to treatment.

New Epilepsia Supplement Reveals Advances in Antiseizure Medications for Epilepsy Patients #United_States #SK_Life_Science #Paramus #XCOPRI #Epilepsia

SK Life Science Unveils Groundbreaking Insights on XCOPRI® at AES 2024 Annual Meeting SK Life Science presented new data on XCOPRI® at the AES 2024 meeting, highlighting its dual mechanism of action offering fresh hope for epilepsy patients.

SK Life Science Unveils Groundbreaking Insights on XCOPRI® at AES 2024 Annual Meeting #United_States #Cenobamate #Epilepsy #Paramus,_New_Jersey #XCOPRI